Walked advanced asset equity recovery out licensing internal?

I can’t tell what “Walked advanced asset equity recovery out licensing internal” refers to. It looks like a fragment of a larger question about (1) asset/equity recovery and (2) “out-licensing” (or licensing) and (3) something “internal,” possibly within a company or a patent/drug context.

Can you clarify what you mean by each part?
- What is the subject: a drug/patent, a company deal, bankruptcy/receivership, or something else?
- What does “advanced asset equity recovery” mean in your context?
- What do you mean by “out licensing internal” (out-licensing internal assets to a partner, or internal licensing between divisions, or internal recovery rights)?
- If this is about a specific drug, what drug name (or company) are you referring to?

Reply with the full sentence or a bit more context, and I’ll produce a clear, search-intent-aware answer.